Eyepoint Pharmaceuticals presented updated DURAVYU data at RetinaSociety2026, adding Phase 3 and real-world evidence on vision outcomes, anatomy, treatment burden and repeat-dosing safety. The update could help shape clinical use as focus shifts to the LUCIA wet AMD trial.
published
Eyepoint Pharmaceuticals presented updated DURAVYU data at RetinaSociety2026, adding Phase 3 and real-world evidence on vision outcomes, anatomy, treatment burden and repeat-dosing safety. The update could help shape clinical use as focus shifts to the LUCIA w
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.